Grants and Contracts per year
Personal profile
Research Interests
- Therapy Resistance
- Cancer Immunotherapy
- Cancer Metabolism
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Post Doctoral Fellow, Yale University
1992
Doctor of Medicine, FuDan University
1988
Doctor of Philosophy, FuDan University
1988
Bachelor of Science, FuDan University
1983
Fingerprint
Dive into the research topics where Jinming Yang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration from the last 5 years on country level. Dive into details by clicking on the dots.
-
Nucleus Accumbens-Associated Protein-1 in Melanoma Immunotherapy
7/3/18 → 11/30/23
Project: Research project
-
Targeting Elongation Factor-2 Kinase to Reinforce Melanoma Immunotherapy
1/1/19 → 9/30/20
Project: Research project
-
Identification of a NACC1-Regulated Gene Signature Implicated in the Features of Triple-Negative Breast Cancer
Ngule, C. M., Hemati, H., Ren, X., Obaleye, O., Akinyemi, A. O., Oyelami, F. F., Xiong, X., Song, J., Liu, X. & Yang, J. M., Apr 2023, In: Biomedicines. 11, 4, 1223.Research output: Contribution to journal › Article › peer-review
Open Access -
Mechanistic insights of NAC1 nuclear export and its role in ovarian cancer resistance to docetaxel
Dong, S. L., Wang, X. H., Yang, S. M., Guo, F. F., Zhang, J. J., Ji, C., Shi, L. R., Cheng, Y., Hu, Y. W., Li, Z. Y., Peng, L., Guo, L. C., Zhu, W. D., Ren, X., Yang, J. M. & Zhang, Y., May 2023, In: Biochemical Pharmacology. 211, 115533.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Targeting lncRNA DDIT4-AS1 Sensitizes Triple Negative Breast Cancer to Chemotherapy via Suppressing of Autophagy
Jiang, T., Zhu, J., Jiang, S., Chen, Z., Xu, P., Gong, R., Zhong, C., Cheng, Y., Sun, X., Yi, W., Yang, J., Zhou, W. & Cheng, Y., Jun 13 2023, In: Advanced Science. 10, 17, 2207257.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
EEF2K promotes PD-L1 stabilization through inactivating GSK3β in melanoma
Chen, X., Wang, K., Jiang, S., Sun, H., Che, X., Zhang, M., He, J., Wen, Y., Liao, M., Li, X., Zhou, X., Song, J., Ren, X., Yi, W., Yang, J., Chen, X., Yin, M. & Cheng, Y., Mar 28 2022, In: Journal for ImmunoTherapy of Cancer. 10, 3, e004026.Research output: Contribution to journal › Article › peer-review
Open Access7 Scopus citations -
Elongation factor-2 kinase is a critical determinant of the fate and antitumor immunity of CD8+ T cells
Das, J. K., Ren, Y., Kumar, A., Peng, H. Y., Wang, L., Xiong, X., Alaniz, R. C., de Figueiredo, P., Ren, X., Liu, X., Ryazonov, A. G., Yang, J. M. & Song, J., Feb 2022, In: Science advances. 8, 5, eabl9783.Research output: Contribution to journal › Article › peer-review